According to Race Oncology's latest financial reports the company has a price-to-book ratio of 0.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2024-12-31 | 12.0 | 116.55% |
2023-12-31 | 5.53 | -37.67% |
2022-12-31 | 8.87 | -78.01% |
2021-12-31 | 40.4 | -9.41% |
2020-12-31 | 44.6 | 988.09% |
2019-12-31 | 4.09 | 453.26% |
2018-12-31 | 0.7401 | -82.34% |
2017-12-31 | 4.19 |